BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6 AND Prognosis
11 results:

  • 1. GDF15 negatively regulates chemosensitivity via tgfbr2-AKT pathway-dependent metabolism in esophageal squamous cell carcinoma.
    Du Y; Ma Y; Zhu Q; Fu Y; Li Y; Zhang Y; Li M; Feng F; Yuan P; Wang X
    Front Med; 2023 Feb; 17(1):119-131. PubMed ID: 36525138
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integrated cohort of esophageal squamous cell cancer reveals genomic features underlying clinical characteristics.
    Li M; Zhang Z; Wang Q; Yi Y; Li B
    Nat Commun; 2022 Sep; 13(1):5268. PubMed ID: 36071046
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive Analysis of the Expression of TGF-
    Song W; Dai WJ; Zhang MH; Wang H; Yang XZ
    Comput Math Methods Med; 2021; 2021():1812227. PubMed ID: 34725559
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Low expression of lncRNA SBF2-AS1 regulates the miR-302b-3p/tgfbr2 axis, promoting metastasis in laryngeal cancer.
    Li Y; Tang B; Lyu K; Yue H; Wei F; Xu Y; Chen S; Lin Y; Cai Z; Guo X; Li C; Lei W
    Mol Carcinog; 2022 Jan; 61(1):45-58. PubMed ID: 34644425
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The downregulation of IGFBP3 by TGF-β signaling in oral cancer contributes to the osteoclast differentiation.
    Park J; Jung MJ; Chung WY
    Biochem Biophys Res Commun; 2021 Jan; 534():381-386. PubMed ID: 33256984
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Circular RNA tgfbr2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107.
    Li W; Lu H; Wang H; Ning X; Liu Q; Zhang H; Liu Z; Wang J; Zhao W; Gu Y; Li H; Sun X; Hu L; Wang D
    Cancer Lett; 2021 Feb; 499():301-313. PubMed ID: 33160003
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. SIX1 maintains tumor basal cells via transforming growth factor-β pathway and associates with poor prognosis in esophageal cancer.
    Nishimura T; Tamaoki M; Komatsuzaki R; Oue N; Taniguchi H; Komatsu M; Aoyagi K; Minashi K; Chiwaki F; Shinohara H; Tachimori Y; Yasui W; Muto M; Yoshida T; Sakai Y; Sasaki H
    Cancer Sci; 2017 Feb; 108(2):216-225. PubMed ID: 27987372
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Novel mutations and expression alterations in SMAD3/tgfbr2 genes in oral carcinoma correlate with poor prognosis.
    Sivadas VP; George NA; Kattoor J; Kannan S
    Genes Chromosomes Cancer; 2013 Nov; 52(11):1042-52. PubMed ID: 23913824
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and tgfbr2.
    Harazono Y; Muramatsu T; Endo H; Uzawa N; Kawano T; Harada K; Inazawa J; Kozaki K
    PLoS One; 2013; 8(5):e62757. PubMed ID: 23690952
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Medullary carcinoma of the thyroid gland (sporadic, familial)].
    Paunović I; Diklić A; Krgović K; Zivaljević V; Tatić S; Havelka M; Kalezić N; Todorovic-Kazić M; Bozić V
    Acta Chir Iugosl; 2003; 50(3):113-20. PubMed ID: 15179766
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis.
    Logullo AF; Nonogaki S; Miguel RE; Kowalski LP; Nishimoto IN; Pasini FS; Federico MH; Brentani RR; Brentani MM
    J Oral Pathol Med; 2003 Mar; 32(3):139-45. PubMed ID: 12581383
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.